Sage Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/5/2025

Shares

183,012

Value ($000)

1,669

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/5/2025	1,669	0.0%	183,012	6/30/2025
2025 Q1	4/29/2025	1,373	0.0%	172,731	3/31/2025
2024 Q4	2/4/2025	931	0.0%	171,444	12/31/2024
2024 Q3	11/12/2024	1,308	0.0%	181,099	9/30/2024
2024 Q2	7/25/2024	2,376	0.0%	218,746	6/30/2024
2024 Q1	4/25/2024	3,393	0.0%	181,055	3/31/2024
2023 Q4	1/29/2024	4,243	0.0%	195,813	12/31/2023
2023 Q3	10/24/2023	4,803	0.0%	233,389	9/30/2023
2023 Q2	8/3/2023	11,081	0.0%	235,668	6/30/2023
2023 Q1	5/9/2023	10,458	0.0%	249,248	3/31/2023
2022 Q4	2/14/2023	9,519	0.0%	249,582	12/31/2022
2022 Q3	11/14/2022	14,260	0.0%	364,129	9/30/2022
2022 Q2	8/15/2022	11,363	0.0%	351,784	6/30/2022
2022 Q1	5/11/2022	11,672	0.0%	352,623	3/31/2022
2021 Q4	2/11/2022	14,570	0.0%	342,489	12/31/2021
2021 Q3	11/18/2021	11,214	0.0%	253,083	9/30/2021
2021 Q2	8/11/2021	15,602	0.0%	274,653	6/30/2021
2021 Q1	5/13/2021	14,907	0.0%	199,162	3/31/2021
2020 Q4	2/9/2021	17,925	0.0%	207,207	12/31/2020
2020 Q3	11/12/2020	12,450	0.0%	203,710	9/30/2020
2020 Q2	8/12/2020	8,603	0.0%	206,900	6/30/2020
2020 Q1	5/6/2020	5,979	0.0%	208,118	3/31/2020
2019 Q4	2/14/2020	38,665	0.0%	535,603	12/31/2019